Firas Hamdan
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 3
- T-cell and B-cell Immunology 2
- Oncology 10
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Vincenzo Cerullo (16 shared papers)Beatriz Martins (9 shared papers)Mikaela Grönholm (8 shared papers)Michaela Feodoroff (7 shared papers)Manlio Fusciello (13 shared papers)Sara Feola (11 shared papers)Jacopo Chiaro (11 shared papers)Erkko Ylösmäki (9 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Molecular Therapy — Oncolytics (2 papers)Cancer Research (2 papers)Nature Communications (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- FinlandItalyNetherlands
In The Last Decade
Firas Hamdan
21 papers receiving 491 citations
Peers
Comparison fields: 5 of 69
- Oncology 217
- Immunology 173
- Biotechnology 56
- Genetics 99
- Molecular Biology 163
Countries citing papers authored by Firas Hamdan
This map shows the geographic impact of Firas Hamdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firas Hamdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firas Hamdan more than expected).
Fields of papers citing papers by Firas Hamdan
This network shows the impact of papers produced by Firas Hamdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firas Hamdan. The network helps show where Firas Hamdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Firas Hamdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 106 | |
| 2 | 2021 | 103 | |
| 3 | 2020 | 44 | |
| 4 | 2019 | 32 | |
| 5 | 1996 | 30 | |
| 6 | 2022 | 29 | |
| 7 | 2023 | 26 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 23 | |
| 10 | 2020 | 17 | |
| 11 | 2022 | 16 | |
| 12 | 2024 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2023 | 2 |
About Firas Hamdan
Firas Hamdan is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 500 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (9 papers), Virus-based gene therapy research (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), T-cell and B-cell Immunology (2 papers), RNA Interference and Gene Delivery (2 papers) and vaccines and immunoinformatics approaches (2 papers). The work is most often cited by research in Oncology (217 citations), Immunology (173 citations), Biotechnology (56 citations), Genetics (99 citations) and Molecular Biology (163 citations). Firas Hamdan has collaborated with scholars based in Finland, Italy and Netherlands. Frequent co-authors include Vincenzo Cerullo, Beatriz Martins, Mikaela Grönholm, Michaela Feodoroff, Manlio Fusciello, Sara Feola, Jacopo Chiaro, Erkko Ylösmäki, Karita Peltonen and Cristian Capasso. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Molecular Therapy — Oncolytics, Cancer Research, Nature Communications and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.